Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Keratinocyte growth factor impairs human thymic recovery from lymphopenia.
Coles AJ, Azzopardi L, Kousin-Ezewu O, Mullay HK, Thompson SA, Jarvis L, Davies J, Howlett S, Rainbow D, Babar J, Sadler TJ, Brown JWL, Needham E, May K, Georgieva ZG, Handel AE, Maio S, Deadman M, Rota I, Holländer G, Dawson S, Jayne D, Seggewiss-Bernhardt R, Douek DC, Isaacs JD, Jones JL. Coles AJ, et al. Among authors: azzopardi l. JCI Insight. 2019 May 7;5(12):e125377. doi: 10.1172/jci.insight.125377. JCI Insight. 2019. PMID: 31063156 Free PMC article. Clinical Trial.
The outlook for alemtuzumab in multiple sclerosis.
Williams T, Coles A, Azzopardi L. Williams T, et al. Among authors: azzopardi l. BioDrugs. 2013 Jun;27(3):181-9. doi: 10.1007/s40259-013-0028-3. BioDrugs. 2013. PMID: 23558379
Human autoimmunity after lymphocyte depletion is caused by homeostatic T-cell proliferation.
Jones JL, Thompson SA, Loh P, Davies JL, Tuohy OC, Curry AJ, Azzopardi L, Hill-Cawthorne G, Fahey MT, Compston A, Coles AJ. Jones JL, et al. Among authors: azzopardi l. Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20200-5. doi: 10.1073/pnas.1313654110. Epub 2013 Nov 26. Proc Natl Acad Sci U S A. 2013. PMID: 24282306 Free PMC article.
Predicting autoimmunity after alemtuzumab treatment of multiple sclerosis.
Azzopardi L, Thompson SA, Harding KE, Cossburn M, Robertson N, Compston A, Coles AJ, Jones JL. Azzopardi L, et al. J Neurol Neurosurg Psychiatry. 2014 Jul;85(7):795-8. doi: 10.1136/jnnp-2013-307042. Epub 2013 Dec 24. J Neurol Neurosurg Psychiatry. 2014. PMID: 24368840
Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy.
Tuohy O, Costelloe L, Hill-Cawthorne G, Bjornson I, Harding K, Robertson N, May K, Button T, Azzopardi L, Kousin-Ezewu O, Fahey MT, Jones J, Compston DA, Coles A. Tuohy O, et al. Among authors: azzopardi l. J Neurol Neurosurg Psychiatry. 2015 Feb;86(2):208-15. doi: 10.1136/jnnp-2014-307721. Epub 2014 May 21. J Neurol Neurosurg Psychiatry. 2015. PMID: 24849515 Clinical Trial.
Association between culture and the preference for, and perceptions of, 11 routes of medicine administration: A survey in 21 countries and regions.
Murdan S, Wei L, van Riet-Nales DA, Gurmu AE, Usifoh SF, Tăerel AE, Yıldız-Peköz A, Krajnović D, Azzopardi LM, Brock T, Fernandes AI, Dos Santos ALS, Anto BP, Vallet T, Lee EE, Jeong KH, Akel M, Tam E, Volmer D, Douss T, Shukla S, Yamamura S, Lou X, van Riet BHG, Usifoh CO, Duwiejua M, Ruiz F, Furnham A. Murdan S, et al. Among authors: azzopardi lm. Explor Res Clin Soc Pharm. 2023 Nov 26;12:100378. doi: 10.1016/j.rcsop.2023.100378. eCollection 2023 Dec. Explor Res Clin Soc Pharm. 2023. PMID: 38094713 Free PMC article.
Transforming pharmaceutical education: A needs-based global analysis for policy development.
Etukakpan A, Uzman N, Ozer O, Tofade T, Leite SN, Joda A, Choonara Y, Mwila C, Azzopardi LM, Mantel-Teeuwisse AK, Rahal M, Darwish R, Lee BJ, Shakya R, Gallagher PJ, Moreau P, Lourenço L, McKinnon RA, Altiere RJ. Etukakpan A, et al. Among authors: azzopardi lm. Explor Res Clin Soc Pharm. 2023 Feb 14;9:100234. doi: 10.1016/j.rcsop.2023.100234. eCollection 2023 Mar. Explor Res Clin Soc Pharm. 2023. PMID: 36876147 Free PMC article.
43 results